Periodical (Journal)

  1. PSIthority
  2. Library
  3. Periodicals
ISSN  :   2575-9108 ( Online )   Active

ACS Pharmacology and Translational Science

Aim & Scope
ACS Pharmacology & Translational Science publishes high-quality, innovative research across the broad spectrum of pharmacology, biochemistry, and experimental medicine—from basic and molecular sciences to translational preclinical studies. We also consider clinical studies that address novel mechanisms of action and methodological papers that drive innovation and advance translational research. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest. We encourage authors to use the pre-submission inquiry mechanism to ensure their research’s relevance and appropriateness for publication. [1]

Go to Website

2020 - VOLUME 3, ISSUE 3
16 RESULTS in 183 msec
Targeting Antibiotic Resistance: From Diagnostics to Novel Antibiotics.

J Li , PM Sexton

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 371-372.

  Editorial
0 3
Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

B Baral , MR Mozafari

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 373-400.

  Journal Article Review
0 344
Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?

Z Dhesi , VI Enne , J O'Grady , ... , DM Livermore

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 401-417.

  Journal Article Review
0 80
Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

FR Fields , G Manzo , CK Hind , ... , S Lee

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 418-424.

  Journal Article
0 27
Characterization of the Core Ribosomal Binding Region for the Oxazolidone Family of Antibiotics Using Cryo-EM.

A Wright , K Deane-Alder , E Marschall , ... , MJ Belousoff

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 425-432.

  Journal Article
0 33
Metabolomic Description of Ivacaftor Elevating Polymyxin B Mediated Antibacterial Activity in Cystic Fibrosis Pseudomonas aeruginosa.

R Allobawi , DP Ghelani , EK Schneider-Futschik

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 433-443.

  Journal Article
0 38
Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.

CB Landersdorfer , M Kinzig , R Höhl , ... , F Sörgel

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 444-454.

  Journal Article
0 48
Update to Our Reader, Reviewer, and Author Communities-April 2020.

CJ Burrows , S Wang , HJ Kim , ... , JA Loo

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 455-456.

  Editorial
0 0
The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

Y Zhou , PJ Little , L Downey , ... , D Kamato

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 457-471.

  Journal Article Review
0 205
Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.

S Bhute , D Sarmah , A Datta , ... , P Bhattacharya

ACS Pharmacology and Translational Science, 2020 - VOLUME 3, ISSUE 3, pp 472-488.

  Journal Article Review
0 189